Citius Pharmaceuticals (CTXR)
NASDAQ:CTXR

Citius Pharmaceuticals (CTXR) Stock Investors

1,123 Followers
Based on 609,942 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

0.1% of all portfolios hold CTXR
On average, investors allocate 4.80% of their portfolios to CTXR
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 609,942 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CTXR

0.6%
Last 7
Days
6.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CTXR, out of 609,942 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CTXR Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
2.97%
$1.06
Opened
0.00%
$1.21
Reduced
0.09%
$1.23
Based on the activity of 11,616 investors who made their portfolios public
The table shows changes in CTXR in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CTXR Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
General Electric
5.78%
-0.16%
+2.14%
$89.95B
Industrial Goods
Tilray
4.85%
-0.25%
-1.28%
$2.05B
Basic Materials
Syros Pharmaceuticals
3.91%
-1.14%
-4.42%
$107.60M
Healthcare
Virgin Galactic Holdings
4.32%
-0.52%
-0.90%
$1.54B
Technology
QuantumScape
3.63%
-0.50%
-0.61%
$3.81B
Industrial Goods
fuboTV
3.31%
-0.57%
-2.45%
$550.81M
Technology
Riot Platforms
3.86%
-0.24%
+0.98%
$1.15B
Financial
Marathon Digital Holdings
4.11%
-0.20%
+1.21%
$878.65M
Technology
American Airlines
5.64%
-0.23%
+2.91%
$10.85B
Industrial Goods
Canopy Growth
4.37%
-0.74%
-3.10%
$1.51B
Basic Materials
Based on the activity of 609,942 active portfolios
Open your Smart Portfolio

CTXR Investor Analysis

CTXR investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
9.1%
of CTXR holders
are under 35
Average Segment Performance
Average P/E Ratio13.38
Beta5.09
Dividend Yield5.19%
CTXR investors between 35–55

Between 35–55

18.9%
Last 30 days
Holdings Change
53.2%
of CTXR holders
are between 35–55
Average Segment Performance
Average P/E Ratio11.24
Beta1.01
Dividend Yield5.21%
CTXR investors over 55

Over 55

3.8%
Last 30 days
Holdings Change
37.6%
of CTXR holders
are over 55
Average Segment Performance
Average P/E Ratio11.03
Beta0.89
Dividend Yield4.45%
Overview of age group and performance of CTXR stock investors
See who invests in CTXR according to age group and performance.

FAQ

How many retail Investors hold CTXR?
0.1% of TipRank’s retail investors hold CTXR in their portfolios.
    What is CTXR Investor Sentiment?
    CTXR’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of CTXR in the last 7 days?
      ▼ 0.6% of TipRank’s retail investors changed their holding of CTXR in the last 7 days.
        What percentage of retail investors changed their holding of CTXR in the last 30 days?
        ▲ 6.0% of TipRank’s retail investors changed their holding of CTXR in the last 30 days.
          What is the average age of retail investors who hold CTXR?
          The average age of CTXR Holders is between 35–55.
            What other stocks have CTXR investors also bought?
            CTXR Investors also bought GE, TLRY, SYRS, SPCE, QS, FUBO, RIOT, MARA, AAL, CGC.

              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AAgilent
              ALGNAlign Tech
              ALNYAlnylam Pharma
              BAXBaxter International
              BIOCBiocept

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis